Key players in Point-of-Care Molecular Diagnostics
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Cepheid |
cepheid.com (opens in a new tab) | 231 reports |
| 2 | Abbott Laboratories | — | 2,310 reports |
| 3 |  Roche Diagnostics |
roche-diagnostics.ch (opens in a new tab) | 924 reports |
| 4 | bioMérieux SA | — | 462 reports |
| 5 | Visby Medical | — | 66 reports |
Point-of-Care Molecular Diagnostics reports by place
One report for each place. Each tile opens that place's report.
Regions 7
World report
Africa report
APAC report
Europe report
Latin America report
Middle East report
North America report
Countries 26
Australia report
Brazil report
Canada report
China report
Ecuador report
Egypt report
France report
Germany report
Hong Kong report
India report
Italy report
Japan report
Kenya report
Malaysia report
Mexico report
New Zealand report
Philippines report
Russia report
Saudi Arabia report
Singapore report
South Africa report
Spain report
Thailand report
UAE report
UK report
US report
Compare all 33 places for Point-of-Care Molecular Diagnostics, with active trials
Get the full Point-of-Care Molecular Diagnostics report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.